Demographic characteristics, comorbidities (diabetes, hypertension, renal impairment), laboratory parameters (creatinine, leucocyte count, ALT), inotropic/vasopressor use (norepinephrine, epinephrine, dopamine), coronary interventions (PCI, CABG), and STEMI location (anterior vs inferior). The gene discussed is GPT; the disease is diabetes mellitus.